Genetic modulators of the phenotype in the long QT syndrome: state of the art and clinical impact

Current Opinion in Genetics and Development

Volumn 33, Issue , 2015, Pages 17-24

  Napolitano, Carlo ^a   Novelli, Valeria ^a   Francis, Matthew D ^a   Priori, Silvia G ^b  

^a IRCCS   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL KCNE2;

ALLELE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; GENDER; GENE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; KCNE2 GENE; LONG QT SYNDROME; NOS1AP GENE; PATIENT RISK; PHENOTYPE; PRIORITY JOURNAL; QT INTERVAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; BRUGADA SYNDROME; GENETIC PREDISPOSITION; GENETICS; MUTATION; PATHOLOGY; RISK FACTOR;

BRUGADA SYNDROME; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LONG QT SYNDROME; MUTATION; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84939235248     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2015.06.009     Document Type: Review

References (39)

1. Napolitano C., Bloise R., Monteforte N., Priori S.G. Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation. Circulation 2012, 125:2027-2034.
2. Priori S.G., Wilde A.A., Horie M., et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 2013, 10:1932-1963.
3. Zareba W., Moss A.J., Schwartz P.J., et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med 1998, 339:960-965.
4. Priori S.G., Schwartz P.J., Napolitano C., et al. Risk stratification in the long-QT syndrome. New Engl J Med 2003, 348:1866-1874.
5. Priori S.G., Napolitano C., Schwartz P.J., et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 2004, 292:1341-1344.
6. Moss A.J., Zareba W., Kaufman E.S., et al. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 2002, 105:794-799.
7. Zareba W., Moss A.J., Sheu G., et al. Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome. J Cardiovasc Electrophysiol 2003, 14:1149-1153.
8. Priori S.G., Napolitano C., Schwartz P.J. Low penetrance in the long-QT syndrome: clinical impact. Circulation 1999, 99:529-533.
9. Napolitano C., Priori S.G., Schwartz P.J., et al. Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA 2005, 294:2975-2980.
10. Wilke R.A., Lin D.W., Roden D.M., et al. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat Rev Drug Discov 2007, 6:904-916.
11. Priori S.G., Schwartz P.J., Napolitano C., et al. A recessive variant of the Romano-Ward long-QT syndrome?. Circulation 1998, 97:2420-2425.
12. Lupoglazoff J.M., Cheav T., Baroudi G., et al. Homozygous SCN5A mutation in long-QT syndrome with functional two-to-one atrioventricular block. Circ Res 2001, 89:E16-E21.
13. Yamaguchi M., Shimizu M., Ino H., et al. Compound heterozygosity for mutations Asp611→Tyr in KCNQ1 and Asp609→Gly in KCNH2 associated with severe long QT syndrome. Clin Sci (Lond) 2005, 108:143-150.
14. Tester D.J., Kopplin L.J., Will M.L., Ackerman M.J. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. Heart Rhythm 2005, 2:1099-1105.
15. Westenskow P., Splawski I., Timothy K.W., Keating M.T., Sanguinetti M.C. Compound mutations: a common cause of severe long-QT syndrome. Circulation 2004, 109:1834-1841.
16. Mullally J., Goldenberg I., Moss A.J., et al. Risk of life-threatening cardiac events among patients with long QT syndrome and multiple mutations. Heart Rhythm 2013, 10:378-382.
17. Kobori A., Sarai N., Shimizu W., et al. Additional gene variants reduce effectiveness of beta-blockers in the LQT1 form of long QT syndrome. J Cardiovasc Electrophysiol 2004, 15:190-199.
18. Ye B., Valdivia C.R., Ackerman M.J., Makielski J.C. A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutation. Physiol Genomics 2003, 12:187-193.
19. Nishio Y., Makiyama T., Itoh H., et al. D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome. J Am Coll Cardiol 2009, 54:812-819.
20. Lahtinen A.M., Marjamaa A., Swan H., Kontula K. KCNE1 D85N polymorphism-a sex-specific modifier in type 1 long QT syndrome?. BMC Med Genet 2011, 12:11.
21. Bezzina C.R., Verkerk A.O., Busjahn A., et al. A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization. Cardiovasc Res 2003, 59:27-36.
22. Zhang X., Chen S., Zhang L., et al. Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations. BMC Med Genet 2008, 9:87.
23. Crotti L., Lundquist A.L., Insolia R., et al. KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. Circulation 2005, 112:1251-1258.
24. Nof E., Cordeiro J.M., Perez G.J., et al. A common single nucleotide polymorphism can exacerbate long-QT type 2 syndrome leading to sudden infant death. Circ Cardiovasc Genet 2010, 3:199-206.
25. Barsheshet A., Moss A.J., McNitt S., et al. Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation. Circ Cardiovasc Genet 2011, 4:491-499.
26. Amin A.S., Giudicessi J.R., Tijsen A.J., et al. Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner. Eur Heart J 2012, 33:714-723.
27. Arking D.E., Pfeufer A., Post W., et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 2006, 38:644-651.
28. Sotoodehnia N., Isaacs A., de Bakker P.I., et al. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet 2010, 42:1068-1076.
29. Albert C.M., MacRae C.A., Chasman D.I., et al. Common variants in cardiac ion channel genes are associated with sudden cardiac death. Circ Arrhythm Electrophysiol 2010, 3:222-229.
30. Arking D.E., Junttila M.J., Goyette P., et al. Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals. PLoS Genet 2011, 7:e1002158.
31. Kapoor A., Sekar R.B., Hansen N.F., et al. An enhancer polymorphism at the cardiomyocyte intercalated disc protein NOS1AP locus is a major regulator of the QT interval. Am J Hum Genet 2014, 94:854-869.
32. Crotti L., Monti M.C., Insolia R., et al. NOS1AP is a genetic modifier of the long-QT syndrome. Circulation 2009, 120:1657-1663.
33. Tomas M., Napolitano C., De Giuli L., et al. Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the Long QT Syndrome. J Am Coll Cardiol 2010, 55:2745-2752.
34. Earle N., Yeo Han D., Pilbrow A., et al. Single nucleotide polymorphisms in arrhythmia genes modify the risk of cardiac events and sudden death in long QT syndrome. Heart Rhythm 2014, 11:76-82.
35. de Villiers C.P., van der Merwe L., Crotti L., et al. AKAP9 is a genetic modifier of congenital long-QT syndrome type 1. Circ Cardiovasc Genet 2014, 7:599-606.
36. Duchatelet S., Crotti L., Peat R.A., et al. Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. Circ Cardiovasc Genet 2013, 6:354-361.
37. Paavonen K.J., Chapman H., Laitinen P.J., et al. Functional characterization of the common amino acid 897 polymorphism of the cardiac potassium channel KCNH2 (HERG). Cardiovasc Res 2003, 59:603-611.
38. Tan B.H., Valdivia C.R., Rok B.A., et al. Common human SCN5A polymorphisms have altered electrophysiology when expressed in Q1077 splice variants. Heart Rhythm 2005, 2:741-747.
39. Cheng J., Tester D.J., Tan B.H., et al. The common African American polymorphism SCN5A-S1103Y interacts with mutation SCN5A-R680H to increase late Na current. Physiol Genomics 2011, 43:461-466.